Vendor source

Reviewed 17 Sept 2026

Completeness Strong (69%)

Cerebriu Apollo Brain

Cerebriu

Cerebriu has developed Apollo, a protocol technology aimed at optimizing brain MRI scan acquisition and patient management. It exists of MR Smart Protocol and MR Smart Alert. MR Smart Protocol analyses an initial abbreviated set of images and suggests the most appropriate next sequences based on initial findings. MR Smart Alert detects critical finding at the earliest stages of the MRI examination for the prioritization of radiological review and notification of critical findings to the care team.

Supported by 3 papers

Cerebriu Apollo Brain thumbnail 1
Cerebriu Apollo Brain thumbnail 2

Key Features

  • Real-time results enabling mr protocol adaptation
  • Vizualization of criticial brain pathology candidate findings

General Information

Product name

Cerebriu Apollo Brain

Company

Modality

MR

Main task

Not specified

Subspeciality

Neuro

Disease targeted

Infarcts (except chronic), intracranial tumors (except iso-intense on T2 FLAIR), and intracranial hemorrhages (except isolated intraventricular hemorrhages, microhemorrhages, or those that are not hypointense on SWI/T2* GRE).

Regulatory Information

CE Certification

Pathway:

MDD

Class:

Class I

Verified by Health AI Register

Other certifications

Not specified

Technical Specifications

Patient population age

Not specified

Input

FLAIR, diffusion, T2*/SWI or equivalent

Input format

DICOM

Output

Detection of candidates finding larger than 5 mm3, image annotations

Output format

DICOM SC

Integration

Embedded on the MRI console, Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased

Deployment

Cloud-based, Hybrid solution, Locally on dedicated hardware

Trigger for analysis

Automatically

Processing time

1 - 10 minutes

Population

Patients between 15 and 75 years receiving brain MR

Market Presence

On market since

05-2021

Resellers

Qure.ai

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Subscription

Based on

Number of analyses, Number of installations, Number of users

Source: Vendor | First published: Oct 28, 2023 | Last updated: Sep 17, 2026